In contrast, recent reports have shown that patients with tumors exhibiting low-level CD44 or CD44v6 expression had a worse post-operative survival than those with high levels of CD44 in resected NSCLC patients with AC or SCC histology [16,18]. Here, CD44 is linked to non-small cell lung carcinoma.